Chocolate Touch drug-coated angioplasty balloon for treatment of PAD receives FDA approval

Genesis MedTech Group announced that the US Food and Drug Administration (FDA) has approved the Chocolate Touch drug-coated balloon (DCB) percutaneous transluminal angioplasty (PTA) catheter, developed by TriReme Medical, for the treatment of patients with peripheral arterial disease (PAD) in the superficial femoral artery (SFA) and the popliteal artery.  The Chocolate Touch DCB was shown […]

The post Chocolate Touch drug-coated angioplasty balloon for treatment of PAD receives FDA approval appeared first on Vascular News.

Case report: Recanalisation of a long SFA occlusion with Ultrascore™ Focused Force PTA Balloon lesion preparation and Lutonix™ 018 Drug Coated Balloon angioplasty

This advertorial, sponsored by BD, is intended for healthcare professionals in Europe only. “Improving vessel compliance with focused force longitudinal plaque fracture seems to be a promising strategy instead of standard percutaneous transluminal angioplasty [PTA],” states interventional angiologist Michael Lichtenberg (Arnsberg Vascular Center, Arnsberg, Germany), detailing that the technique avoids “significant vessel damage”. In this […]

The post Case report: Recanalisation of a long SFA occlusion with Ultrascore™ Focused Force PTA Balloon lesion preparation and Lutonix™ 018 Drug Coated Balloon angioplasty appeared first on Vascular News.